A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008) | MicrobiomeTrials← Back to trialsNCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-03Est. Completion: 2030-07-01
Enrollment target: 200 participants Locations- Colorado Blood Cancer Institute ( Site 7000), Denver, Colorado, United States
- SCRI Oncology Partners ( Site 0100), Nashville, Tennessee, United States
- Instituto Alexander Fleming ( Site 1404), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Sanatorio Nuestra Senora del Rosario ( Site 1403), Rosario, Santa Fe Province, Argentina
- Beijing Cancer hospital ( Site 1701), Beijing, Beijing Municipality, China
- Shaare Zedek Medical Center ( Site 0603), Jerusalem, Israel
- Haddasah Medical Center ( Site 0600), Jerusalem, Israel
- Sheba Medical Center ( Site 0601), Ramat Gan, Israel
- Sourasky Medical Center. ( Site 0604), Tel Aviv, Israel
- INOC - Istituto Nazionale Oncologico Candiolo ( Site 0701), Candiolo, Piedmont, Italy
- Pratia MCM Krakow ( Site 0903), Krakow, Lesser Poland Voivodeship, Poland
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( Site 0900), Warsaw, Masovian Voivodeship, Poland
- Pratia Onkologia Katowice ( Site 0902), Katowice, Silesian Voivodeship, Poland
- Institut Català d'Oncologia (ICO) - Badalona ( Site 1103), Badalona, Barcelona, Spain
Other microbiome trials you might be interested in
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt LymphomaNeuroblastomaEwing Sarcoma
Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab…
Los Angeles, United StatesEst. completion Mar 31, 2029
Recurrent Burkitt LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 RearrangementsRefractory Burkitt Lymphoma
Hospital Virgen de la Victoria ( Site 1104), Málaga, Malaga, SpainHospital Universitari Vall de Hebron ( Site 1102), Barcelona, SpainHospital Universitario Gregorio Maranon ( Site 1101), Madrid, SpainHospital Universitario 12 de Octubre ( Site 1105), Madrid, SpainHacettepe Universitesi Tip Fakultesi Hastanesi ( Site 1000), Ankara, Turkey (Türkiye)Koç Üniversitesi Hastanesi ( Site 1001), Istanbul, Turkey (Türkiye)Derriford Hospital ( Site 1304), Plymouth, Devon, United KingdomThe Christie NHS Foundation Trust ( Site 1300), Manchester, United KingdomRefractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
This phase II/III trial tests adding glofitamab to standard of care chemoimmunotherapy in patients with Burkitt and high…
Multiple LocationsEst. completion Nov 1, 2033